MSA Safety MSA Q1 2026 Earnings Solid EPS Beat Amid Steady Demand IREN Q1 2026 Earnings Massive EPS Miss Weighs on Sentiment MTUS Q1 2026 Earnings EPS Surpasses Estimates by 1765 Unicycive Therapeutics UNCY Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Continues Development Lexaria Bioscience Corp LEXX Q1 2026 Earnings EPS Beat by 38 Despite No Revenue SLB Q1 2026 Earnings Marginal EPS Miss Stock Edges Up Amid Mixed Market Signals